Literature DB >> 10473531

Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis.

P C Baldi1, G F Araj, G C Racaro, J C Wallach, C A Fossati.   

Abstract

The diagnosis of human neurobrucellosis usually relies on the detection of antibodies to Brucella lipopolysaccharide (LPS) in cerebrospinal fluid (CSF) by agglutination tests or enzyme-linked immunosorbent assay (ELISA). Here we describe the detection of immunoglobulin G (IgG) to cytoplasmic proteins (CP) of Brucella spp. by ELISA and Western blotting in seven CSF samples from five patients with neurobrucellosis. While IgG to CP (titers of 200 to 12, 800) and IgG to LPS (800 to 6,400) were found in the CSF of these patients, these antibodies were not detected in CSF samples from two patients who had systemic brucellosis without neurological involvement. The latter, however, had serum IgG and IgM to both LPS and CP. No reactivity to these antigens was found in CSF samples from 14 and 20 patients suffering from nonbrucellar meningitis and noninfectious diseases, respectively. These findings suggest that, in addition to its usefulness in the serological diagnosis of human systemic brucellosis, the ELISA with CP antigen can be used for the specific diagnosis of human neurobrucellosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473531      PMCID: PMC95768          DOI: 10.1128/CDLI.6.5.756-759.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  12 in total

1.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

2.  Clinical categories of neurobrucellosis. A report on 19 cases.

Authors:  R A Shakir; A S Al-Din; G F Araj; A R Lulu; A R Mousa; M A Saadah
Journal:  Brain       Date:  1987-02       Impact factor: 13.501

3.  Oligoclonal gamma-globulin of cerebrospinal fluid in neurobrucellosis.

Authors:  C A Silva; M E Rio; A Maia-Gonçalves; S Pereira; M Palmeira; M R Brito; C Cruz
Journal:  Acta Neurol Scand       Date:  1980-01       Impact factor: 3.209

4.  ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis.

Authors:  G F Araj; A R Lulu; M I Khateeb; M A Saadah; R A Shakir
Journal:  APMIS       Date:  1988-02       Impact factor: 3.205

5.  Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses.

Authors:  F A Goldbaum; C P Rubbi; J C Wallach; S E Miguel; P C Baldi; C A Fossati
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

6.  Brucella abortus cytoplasmic proteins used as antigens in an ELISA potentially useful for the diagnosis of canine brucellosis.

Authors:  P C Baldi; M M Wanke; M E Loza; C A Fossati
Journal:  Vet Microbiol       Date:  1994-07       Impact factor: 3.293

7.  Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species.

Authors:  P C Baldi; S E Miguel; C A Fossati; J C Wallach
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

8.  Rapid diagnosis of central nervous system brucellosis by ELISA.

Authors:  G F Araj; A R Lulu; M A Saadah; A M Mousa; I L Strannegard; R A Shakir
Journal:  J Neuroimmunol       Date:  1986-09       Impact factor: 3.478

9.  Urban outbreak of a Brucella melitensis infection in an Argentine family: clinical and diagnostic aspects.

Authors:  J C Wallach; S E Miguel; P C Baldi; E Guarnera; F A Goldbaum; C A Fossati
Journal:  FEMS Immunol Med Microbiol       Date:  1994-01

10.  Antigenic relationship of the gram-negative organism causing canine abortion to smooth and rough brucellae.

Authors:  R Diaz; L M Jones; J B Wilson
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  7 in total

1.  Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis.

Authors:  George F Araj; Mireille M Kattar; Layla G Fattouh; Kayane O Bajakian; Sara A Kobeissi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Neurobrucellosis associated with syndrome of inappropriate antidiuretic hormone with resultant diabetes insipidus and hypothyroidism.

Authors:  Giuseppe Sturniolo; Placido Mondello; Salvatore Bruno; Orsola Elena Bonfatto; Sabrina Frattima; Antonio Albanese; Roberta Restivo; Giuseppe Liberti; Paolo Pasquali; Cinzia Marianelli
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

3.  Case Report: Neurobrucellosis with Plastered Spinal Arachnoiditis: A Magnetic Resonance Imaging-Based Report.

Authors:  Saraswati Nashi; Veeramani Preethish-Kumar; Sayani Maji; Nagarathna Chandrashekar; Kiran Polavarapu; Chetan Kashinkunti; Kajari Bhattacharya; Jitender Saini; Atchayaram Nalini
Journal:  Am J Trop Med Hyg       Date:  2018-01-11       Impact factor: 2.345

Review 4.  Chronic meningitis.

Authors:  Bruce A Cohen
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 6.030

5.  Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases.

Authors:  M Cruz Miraglia; Romina Scian; Clara García Samartino; Paula Barrionuevo; Ana M Rodriguez; Andrés E Ibañez; Lorena M Coria; Lis N Velásquez; Pablo C Baldi; Juliana Cassataro; M Victoria Delpino; Guillermo H Giambartolomei
Journal:  J Neuroinflammation       Date:  2013-04-12       Impact factor: 8.322

6.  Subarachnoid hemorrhage secondary to Brucella-induced cerebral aneurysm: a case report.

Authors:  Yanyan Guan; Nannan Xu; Yongyuan Yao; Feng Zheng; Fengzhe Chen; Wei Wang; Xiaomeng Dong; Gang Wang
Journal:  BMC Infect Dis       Date:  2021-07-31       Impact factor: 3.090

7.  A case of brucellosis-induced Guillain-Barre syndrome.

Authors:  Qian Li; Jianfeng Liu; Wenhui Jiang; Lisheng Jiang; Mengzhi Lu; Linping Xiao; Yukun Li; Yinghua Lan; Yongguo Li
Journal:  BMC Infect Dis       Date:  2022-01-20       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.